p21 antibody
CDKN1A
Reactivity: Human
WB, IP
Host: Mouse
Monoclonal
0-T-180-0-T-180A
unconjugated
-
-
Target
See all p21 (CDKN1A) Antibodies
-
p21 (CDKN1A)
(Cyclin-Dependent Kinase Inhibitor 1A (p21, Cip1) (CDKN1A))
-
Reactivity
-
Human
-
Host
-
Mouse
-
Clonality
-
Monoclonal
-
Conjugate
-
This p21 antibody is un-conjugated
-
Application
-
Western Blotting (WB), Immunoprecipitation (IP)
-
Cross-Reactivity
-
Human, Mouse (Murine)
-
Cross-Reactivity (Details)
-
Calculated cross reactivity: Hu Mo
-
Characteristics
-
WAF1, p21 (Wild-type p53-activated Fragment, Cip1, Sdi1, Pic1 Tumor Suppressor Protein)
-
Purification
-
Purified by Protein G affinity chromatography.
-
Immunogen
-
Recombinant full-length WAF1, p21 (Wild-type p53-activated Fragment, Cip1) with a histidine tag.
-
Clone
-
0-T-180-0-T-180A
-
Isotype
-
IgG1 kappa, IgG2b kappa
-
Top Product
-
Discover our top product CDKN1A Primary Antibody
-
anti-Cyclin-Dependent Kinase Inhibitor 1A (p21, Cip1) (CDKN1A) (AA 21-100) antibody
CDKN1A
Reactivity: Human, Mouse, Rat, Sheep
WB, ELISA, FACS, IHC (p), IF (cc), IF (p), ICC, IHC (fro)
Host: Rabbit
Polyclonal
unconjugated
-
-
Application Notes
-
Optimal working conditions should be determined by the investigator.
-
Restrictions
-
For Research Use only
-
-
Format
-
Liquid
-
Buffer
-
Supplied as liquid in 0.1M Tris-glycine, pH 7.4, 0.15M sodium chloride, 0.05 % sodium azide.
-
Preservative
-
Sodium azide
-
Precaution of Use
-
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
-
-20 °C
-
Storage Comment
-
-20°C
-
-
Target
-
p21 (CDKN1A)
(Cyclin-Dependent Kinase Inhibitor 1A (p21, Cip1) (CDKN1A))
-
Alternative Name
-
WAF1, p21 (CDKN1A Products)
-
Synonyms
-
CCND1 antibody, CDKN1A antibody, CAP20 antibody, CDKN1 antibody, CIP1 antibody, MDA-6 antibody, P21 antibody, SDI1 antibody, WAF1 antibody, p21CIP1 antibody, CDKI antibody, Cdkn1 antibody, Waf1 antibody, mda6 antibody, p21Cip1 antibody, p21WAF antibody, Cip1 antibody, UV96 antibody, p21 antibody, cip1 antibody, p16Xic2 antibody, sdi1 antibody, waf1 antibody, cap20 antibody, cdkn1 antibody, mda-6 antibody, p21cip1 antibody, si:ch1073-48m5.2 antibody, KRAS2 antibody, p21ras antibody, cyclin D1 antibody, cyclin dependent kinase inhibitor 1A antibody, cyclin-dependent kinase inhibitor 1A (P21) antibody, cyclin-dependent kinase inhibitor 1A antibody, cyclin-dependent kinase inhibitor 1A L homeolog antibody, cyclin-dependent kinase inhibitor 1 antibody, KRAS proto-oncogene, GTPase antibody, CCND1 antibody, CDKN1A antibody, Cdkn1a antibody, cdkn1a.L antibody, cki1 antibody, cdkn1a antibody, KRAS antibody
-
Pathways
-
p53 Signaling, PI3K-Akt Signaling, Cell Division Cycle, AMPK Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Mitotic G1-G1/S Phases, DNA Replication, Hepatitis C, Synthesis of DNA, Autophagy
-